Quantum BioPharma Taps Thermo Fisher for Lucid-MS Trial
Quantum BioPharma has signed an agreement with Thermo Fisher's PPD Clinical Research Business to implement its FDA-cleared Phase 2 trial for Lucid-MS in progressive multiple sclerosis.
Quantum BioPharma has signed an agreement with Thermo Fisher's PPD Clinical Research Business to implement its FDA-cleared Phase 2 trial for Lucid-MS in progressive multiple sclerosis.